IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
4
Neutral
4
Bullish
6
Bearish
30
Neutral
4
Bullish
12
Bearish
26
Neutral
0
Bullish
6
Bearish
26
Neutral
0
Bullish
6
Bearish
26
Neutral
0
Bullish
6
Bearish
26
Neutral
0
Bullish
6
Checkpoint Trends Limited (formerly Rubra Medicaments Limited) is a small, publicly listed company that now describes its core activity as trading and providing consultancy services; it was established in 1991 and historically engaged in pharmaceutical formulation manufacturing before pivoting its stated business model to trading/consultancy and rebranding in April 2022.
The most recent audited financial information provided (FY2015) shows effectively zero reported operating revenue for the period, with a materially negative reserves and surplus balance of INR (50.77) million and paid-up equity capital of INR 54.68 million, indicating accumulated losses and very limited profitable operating history at scale.
Balance-sheet dynamics in FY2015 show an unusually large long-term loans and advances line that dropped from INR 33.05 million to INR 3.05 million year-on-year, while cash and bank balances fell from INR 4.36 million to INR 1.25 million, signalling constrained liquidity and substantial prior related-party or recoverable balances being adjusted.
Shareholding structure is atypical: public shareholders hold about 99.95% of equity while promoters hold just 0.05% (3,000 shares), suggesting low promoter skin-in-the-game, high public float, potential governance and strategic-control implications, and limited promoter commitment to capital infusion or direction at the time of the filing.
Pharmaceuticals & Biotechnology
Pharmaceuticals
18 Cr
Low Risk
14.3
39.5
0.0
8.5
144.40
28.42
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: Nov 12, 2026
Centuple Global Ltd (CHECKPOINT) is currently trading at 33.57 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Checkpoint Trends Limited (formerly Rubra Medicaments Limited) is a small, publicly listed company that now describes its core activity as trading and providing consultancy services; it was established in 1991 and historically engaged in pharmaceutical formulation manufacturing before pivoting its stated business model to trading/consultancy and rebranding in April 2022. The most recent audited financial information provided (FY2015) shows effectively zero reported operating revenue for the period, with a materially negative reserves and surplus balance of INR (50.77) million and paid-up equity capital of INR 54.68 million, indicating accumulated losses and very limited profitable operating history at scale. Balance-sheet dynamics in FY2015 show an unusually large long-term loans and advances line that dropped from INR 33.05 million to INR 3.05 million year-on-year, while cash and bank balances fell from INR 4.36 million to INR 1.25 million, signalling constrained liquidity and substantial prior related-party or recoverable balances being adjusted. Shareholding structure is atypical: public shareholders hold about 99.95% of equity while promoters hold just 0.05% (3,000 shares), suggesting low promoter skin-in-the-game, high public float, potential governance and strategic-control implications, and limited promoter commitment to capital infusion or direction at the time of the filing.
Over the past 52 weeks, Centuple Global Ltd has traded between a low of ₹28.42 and a high of ₹144.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Centuple Global Ltd has a market capitalization of approximately 17.59. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Centuple Global Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 14.30 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 17.59 Cr, Centuple Global Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Centuple Global Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Centuple Global Ltd is 14.30. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
3.40 | 18 Cr | 456.75 | 2.41 | 0.00 | 0.56 | 0.30 | 0.37 | ||
10.25 | 18 Cr | 51.74 | 0.57 | 0.00 | 1.12 | 4.42 | 0.29 | ||
32.16 | 18 Cr | 14.30 | 8.51 | 0.00 | 6.49 | 7.62 | 0.36 | ||
66.50 | 17 Cr | 6.03 | 1.32 | 0.00 | 3.90 | 5.40 | 18.86 | ||
106.50 | 16 Cr | -79.90 | 12.80 | 0.00 | -15.95 | -15.74 | -10.93 | ||
36.00 | 15 Cr | 4.15 | 0.76 | 0.00 | 20.15 | 30.12 | 10.11 | ||
38.00 | 15 Cr | 9.49 | 0.88 | 0.00 | 9.36 | 11.66 | 3.86 | ||
| Median: 7 Co. | — | 36.00 | 17 Cr | 9.49 | 1.32 | 0.00 | 3.90 | 5.40 | 0.37 |
